Tolerance to Fluid Removal During Continuous Renal Replacement Therapy in Critically Ill Adults with Acute Kidney Injury
Led by Hospital Las Higueras · Updated on 2026-07-08
128
Participants Needed
10
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying adults with acute kidney injury AKI who are critically ill and receiving continuous renal replacement therapy CRRT. The study aims to understand how well patients tolerate fluid removal through net ultrafiltration UFNET during CRRT. This is an observational study focusing on how changes in heart function, blood flow, tissue perfusion, and congestion-related signs might predict intolerance to fluid removal before severe low blood pressure occurs.
Participants are critically ill adults receiving CRRT with UFNET prescribed by their clinical care team. The study does not change or assign treatments but monitors patients using multiple methods. These include clinical assessments, hemodynamic monitoring, cardiac ultrasound, venous congestion evaluation, peripheral perfusion measurements, biochemical tests, and fluid balance tracking. Data is collected before and during the early phase of fluid removal, with additional recordings if signs of intolerance appear.
Participants will be assessed at scheduled times using standard medical records, bedside monitors, laboratory results, and ultrasound exams. The study will track the development of ultrafiltration intolerance within 24 hours of UFNET start. Researchers will analyze various physiological and clinical factors to identify predictors of intolerance. The study may help tailor fluid removal strategies and improve CRRT safety in critically ill patients with AKI. Participation includes monitoring without altering usual care, and data will be kept confidential and anonymized.
CONDITIONS
Brief Title
Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients
Research Team
G
Gonzalo Ramírez-Guerrero, MD
C
Cristian Pedreros-Rosales, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Observation and Monitoring
Duration - Up to 24 hours from start of net ultrafiltration
Participants are monitored using clinical evaluations, ultrasound, hemodynamic, perfusion, and biochemical assessments before and during fluid removal by continuous renal replacement therapy.
Multiple assessments during treatment period
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Study of Staff Training to Improve ICU Care and Reduce Post-Intensive Care Syndrome in Adults
A Phase 2 Double-Blind Study Comparing Kidney Protection of Cilastatin Versus Thiosulfate
in Women Undergoing Debulking Surgery with Heated Intraperitoneal Cisplatin Chemotherapy
Study to Validate and Develop the Multifactorial Dynamic Perfusion Index MDPI for Predicting Kidney Injury and Other Complications After Cardiac Surgery with Cardiopulmonary Bypass in Adults and Infants
Creating a Multi-Center Data System and Network in China to Study Severe Infection and Sepsis in Children from Newborn to 18 Years
Combination of Sleep Promotion and Cognitive Training to Improve Brain Function in Older Adults After ICU Stay
COPE-AKI Trial Evaluating a Team-Based Care Approach for Patients After Acute Kidney Injury to Improve Hospital-Free Days and Kidney Outcomes
Comparing Kidney Injury Risks of Vancomycin with Piperacillin-Tazobactam Versus Vancomycin with Cefepime in Hospitalized Adults
Study of Early Restart Versus Usual Care of Renin-Angiotensin System Inhibitors After Acute Kidney Injury in Hospitalized Adults
Improving Care for Children Ages 1 to 18 with Acute Kidney Injury Using a Mobile Health Educational Tool
Evaluating PrismaLung Device for Carbon Dioxide Removal in Critically Ill Patients on Mechanical Ventilation A Randomized Controlled Trial
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Utility of the Venous Excess Ultrasound (VEXUS) score to track dynamic change in volume status in patients undergoing fluid removal during haemodialysis - the ACUVEX study.
Fluid balance neutralization secured by hemodynamic monitoring versus protocolized standard of care in patients with acute circulatory failure requiring continuous renal replacement therapy: results of the GO NEUTRAL randomized controlled trial.
Perfusion variables and hemodynamic phenotypes during fluid removal via net ultrafiltration in continuous renal replacement therapy: a retrospective single-center cohort study.